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http://www.biomedcentral.com/1471-2458/13/221RESEARCH ARTICLE Open AccessBreaking the habit: a qualitative exploration of
barriers and facilitators to smoking cessation in
people with enduring mental health problems
Susan Kerr1*, Charlotte Woods2, Christina Knussen1, Hazel Watson2 and Robert Hunter3Abstract
Background: Smoking in people with mental health problems (MHPs) is an important public health concern as
rates are two to three times higher than in the general population. While a strong evidence base exists to
encourage and support smoking cessation in the wider population, there is limited evidence to guide the tailoring
of interventions for people with MHPs, including minimal understanding of their needs. This paper presents
findings from theoretically-driven formative research which explored the barriers and facilitators to smoking
cessation in people with MHPs. The aim, guided by the MRC Framework for the development and evaluation of
complex interventions, was to gather evidence to inform the design and content of smoking cessation
interventions for this client group.
Methods: Following a review of the empirical and theoretical literature, and taking a critical realist perspective, a
qualitative approach was used to gather data from key stakeholders, including people with enduring MHPs (n = 27)
and professionals who have regular contact with this client group (n = 54).
Results: There was a strong social norm for smoking in participants with MHPs and most were heavily addicted to
nicotine. They acknowledged that their physical health would improve if they stopped smoking and their disposable
income would increase; however, more important was the expectation that, if they attempted to stop smoking, their
anxiety levels would increase, they would lose an important coping resource, they would have given up something
they found pleasurable and, most importantly, their mental health would deteriorate. Barriers to smoking cessation
therefore outweighed potential facilitators and, as a consequence, impacted negatively on levels of motivation and
self-efficacy. The potential for professionals to encourage cessation attempts was apparent; however, they often failed
to raise the issue of smoking/cessation as they believed it would damage their relationship with clients. The
professionals’ own smoking status also appeared to influence their health promoting role.
Conclusions: Many opportunities to encourage and support smoking cessation in people with MHPs are currently
missed. The increased understanding provided by our study findings and literature review have been used to shape
recommendations for the content of tailored smoking cessation interventions for this client group.Background
People with mental health problems (MHPs) are twice as
likely to die from heart disease and their risk of dying
from respiratory disorders is four times that of the general
population [1]. The prevalence of cancer is also high, with
a 29% excess in mortality remaining after adjusting for* Correspondence: s.m.kerr@gcu.ac.uk
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reproduction in any medium, provided the ordemographic factors and co-morbidity [2]. The causes of
these health inequalities are multiple and complex; how-
ever, health behaviours are known to be important. One
health behaviour of particular note in this client group is
smoking. Smoking is two to three times more common in
people with MHPs than in the general population, with
levels being as high as 70 to 80% in people with schizo-
phrenia [3,4]. While the prevalence of smoking is high, 50
to 70% of people with MHP say that they would like to
stop [4]. It is therefore of some concern that smoking ces-
sation rates in this population are low [5].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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on the physical health of people with MHPs have focussed
on smoking and smoking cessation in this client group
[1,6]. A strong evidence base supports guidance on cessa-
tion support for the general population [7]. Behavioural
support and pharmacotherapies (including nicotine re-
placement therapy (NRT), varenicline and buproprion)
are effective in helping people stop smoking and these
treatment approaches are recommended in combination,
where possible [7]. Clinical trials demonstrate that special-
ist support with pharmacotherapy quadruples the chance
of successfully stopping smoking [7,8]. However, while a
strong evidence base supports guidance on cessation sup-
port for the general population, the evidence base for
people with enduring MHPs is limited. Recent systematic
reviews demonstrate that bupropion can be effective for
this client group [9,10]. There are, however, a number of
contra-indications to its use, and it is rarely prescribed for
people with or without MHPs in the UK [11]. Worldwide,
there are few robust trials of the efficacy of NRT or
varenicline for people with MHP [9,12]. A lack of tailored
behavioural interventions for this client group has also
been highlighted [9]; this includes brief interventions to
encourage consideration of a quit attempt and intensive
interventions to support cessation. The current lack of
evidence/guidance in this area is thought to function as an
important impediment to successful quitting and public
health advocates have highlighted the need for further re-
search into the reasons people with MHPs smoke and bar-
riers to cessation [13]. Also, the UK’s National Institute
for Health and Clinical Excellence (NICE) has recently
called for evidence to support guidance in this area [14].
Cognisant of the above, and following the Medical Re-
search Council’s guidance on the development and evalu-
ation of complex interventions [15], we are undertaking a
programme of research that aims to develop and evaluate
tailored smoking-cessation interventions for people with
enduring MHPs. Our programme forms part of a small
body of formative research in this area being led by re-
searchers in the UK and internationally. In the develop-
mental phase of our research we reviewed the empirical
and theoretical literature and interviewed key stakeholders.
In this paper we report findings from interviews with
people with MHPs and members of the multi-disciplinary
team of professionals who have regular contact with this
client group. Our aim was to determine the principal bar-
riers and facilitators to cessation in people with MHPs and
for the information to be used to inform the design and
content of tailored smoking cessation interventions.
Methods
A qualitative approach was adopted, guided by a critical
realist perspective [16,17]. The phenomenon of interest
(i.e. the smoking-related behaviour of people withMHPs) was explored through the lens of social cognitive
theory (SCT) [18]. SCT can be used as a framework to
explain how and why people acquire and maintain
behavioural patterns; it can also inform the design, im-
plementation and evaluation of behaviour-change inter-
ventions [19]. It was, therefore, considered useful for our
purposes. Social cognitive theory proposes that a person’s
behaviour both influences and is influenced by environ-
mental factors (including other people’s behaviour and
social norms), personal factors (including motivation) and
attributes of the behaviour itself [18]. Central tenets of
SCT include self-efficacy and the value placed on the
perceived outcomes or consequences of a change in
behaviour [18].
Participants were recruited by one of the authors (CW)
from three Health Boards that serve a large geographical
area in the west and south of Scotland. The target popula-
tions were smokers who had an enduring mental health
problem and members of the multi-disciplinary health
and social care team who had regular contact with this cli-
ent group. Participants were recruited purposively [20]
from urban and rural areas with varying levels of socio-
economic deprivation.
People with MHPs were recruited with the assistance of
key workers in community-based mental health teams.
Eligibility criteria included: being a current smoker; pres-
ence of an enduring mental health problem i.e. schizo-
phrenia/delusional disorder, an affective disorder or a
neurotic/stress-related disorder [21]; being 18 years or
older; living at home in the community at the time of re-
cruitment. People were excluded if they had florid or very
active symptoms of mental illness. The aim was to recruit
25 people with MHPs.
Health and social care professionals (HSCPs) were
recruited with the assistance of senior managers in
Community Mental Health Teams and the Scottish Pri-
mary Care Research Network. Participants included psy-
chiatrists, mental health nurses, occupational therapists,
psychologists, general practitioners and social workers.
To be eligible to participate, the professionals had to
have regular contact with people with MHPs. The aim
was to recruit 50 HSCPs.
Ethical approval was granted by the Multi-Site Research
Ethics Committee (MREC) in Scotland. The principles of
the UK Data Protection Act (2003) were observed. All par-
ticipants provided informed consent.
The data were collected by CW during one-to-one inter-
views (outlines of the interview guides are presented in
Table 1). Participants with MHPs were normally
interviewed in their own homes, with HSCPs being inter-
viewed on the telephone. The interviews were digitally-
recorded and lasted between 30 and 60 minutes.
Following verbatim transcription, the data were
analysed with the assistance of qualitative analysis
Table 1 Interview guides
People with mental health problems (MHPs) Health and social care professionals
- Smoking history (age started; why started; consumption) - Experience of working with people with MHPs who smoke
- Perceived positive and negative aspects to smoking - Views on why people with MHPs smoke
- Times when smoke more or less - Smoking cessation (views on barriers and facilitators in people
with MHPs)
- Contact with others who smoke
- Own role in encouraging/supporting smoking cessation
(views on barriers and facilitators)
- Others’ views on smoking (friends, family, professionals)
- Views and experience of specialist smoking cessation services for
people with MHPs
- Perceived positive and negative aspects to smoking cessation
(barriers and facilitators)
- Knowledge of smoking cessation guidelines
- Views and experience of existing smoking cessation
services/support
- Training and education (smoking + smoking cessation)- Impact of mental health problem (if any) on smoking/smoking
cessation
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‘framework analysis’, a method commonly used in the
applied health field, the data were analysed both de-
ductively and inductively [22,23]. Key issues and con-
cepts were initially identified by drawing on a priori
reasoning and linked to questions in the interview
guide. The data were then indexed thematically (and in-
ductively) based on the participants’ discussion of key
barriers and facilitators to smoking/smoking cessation.
In the final stage, and with the aim of understanding
the mechanisms involved, the findings were viewed
through the lens of social cognitive theory. Data analysis
was undertaken by SK and discussed and agreed
with CK.Results
Participants’ characteristics
Twenty-seven people with MHPs were recruited. A
profile of the participants is presented in Table 2.
Dependence on nicotine was assessed using the
Fagerström Test for Nicotine Dependence, a six-item
validated instrument commonly used in the smoking
cessation field [24]. The majority of the participants
were heavily addicted to nicotine (n = 24; 88.9%).
Fifty-four HSCPs from six professional groups were
recruited, with a median age of 44 years. A profile of the
HSCPs is presented in Table 3.
When presenting the findings, identifiers have been
used in the brackets that precede the quotes. The
participants’ names have been replaced with pseudo-
nyms and the second identifier provides information
on the participants’ diagnosis, i.e. S (schizophrenia),
A (affective disorder), N (neurotic disorder), or pro-
fessional group, N (mental health nurse), OT (occupa-
tional therapist), psychia. (psychiatrist), psychol.
(psychologist), GP (general practitioner), SW (social
worker).Views of participants with mental health problems
Barriers to smoking cessation
While ultimately unsuccessful, the majority of the
participants had made a cessation attempt at some
point; some had made a few. The length of time
stopped varied from less than 4 weeks (n = 7), to
more than a year (n = 4), with most using pharmaco-
therapy (normally NRT) and a small number
accessing behavioural support (group or one-to-one)
during the cessation attempt (n = 4). Only three of
the participants stated that they had never tried to
stop smoking. While reporting that they would like to
stop smoking, many factors were discussed that func-
tioned as barriers to cessation; these included social
norms, using tobacco as a form of self-medication,
the impact of their mental health problem, the pleas-
ure/enjoyment associated with smoking, low levels of
motivation and self-efficacy and lack of professional
support.
The smoking habits of family and friends and other
mental health service users (social norms) were
discussed at length and were clearly influential. Smoking
was strongly linked to socialising and many were
concerned that if they stopped it might have a negative
impact on relationships that were important to them.
[Alison, A] When I am here at the Centre [mental
health resource centre] most of the smoking that I do
is like going outside wi’ other people who smoke. It’s
no because I really want to smoke, it’s just more of a
case of joining in.
The general perception was that smoking had a
calming effect, helping the participants deal with the
general stresses and strains of everyday life and some
anxieties linked to their mental health problem. There
was a concern in many that if they stopped smoking
they would lose an important coping strategy/resource.
Table 2 People with MHPs (demographic variables)
n = 27 Frequency Percent
Sex
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calming effect. If I’ve got something on that’s stressful,
I’ll light up, and that seems to pull me together.male 11 41
female 16 59
Age
30-39 years 6 22
40-49 years 10 37
50-59 years 10 37
60 + years 1 4







Schizophrenia/delusional disorder 11 41
Affective disorder 8 30
Neurotic disorder 1 4
Schizo-affective disorder 6 22
Neurotic-affective disorder 1 4[Marion, A/N] It’s a crutch. And to be honest . . . I
wouldn’t cope if I didn’t have my cigarettes. I know
when I’ve tried to stop and I have stopped in the past, it’s
been something that’s happened, like a trauma or a big
decision to make which has made me go back on them.
Some were concerned that their mental health would
deteriorate if they stopped /tried to stop smoking.
[Lynn, S] I’m a schizophrenic and I start to hear
voices and it starts getting bad [if I try to stop
smoking]. I start to panic. [Smoking has] helped to
keep me together over the past years . . . . When I
stop [smoking] I’m feart [scared] to get the voices and
end up going in and out of the hospital.
Others discussed the impact that deterioration in their
mental health could have on their smoking.
[Jenny, A] If I’m particularly depressed then I’m in the
house and I’m no’ going out and I’m no seeing




Scottish Index of Multiple Deprivation [25] – participants’ postcodes
used to calculate scores. Data zones grouped into quintiles. Areas
scoring 1 most deprived, areas scoring 5 least deprived.
Fagerström test for Nicotine dependence
1-5 3 11
6-10 (heavily addicted) 24 89
Note: All percentages have been rounded up/down and so may not add up
to 100%.[Jim, S/A] If I’m hyper. I’ll chain smoke. Really heavy,
and that goes on all night. I mean the worst thing in
my view about being hyper. is the fact that you seem
to have lungs like sponges.
A small number of the participants commented on
how the stimulant effect of smoking helped to overcome
some of the side-effects of psychiatric medications, par-
ticularly antipsychotics.
[Peter, S] I take my tablets at night and don’t surface
until the afternoon. I’m knackered when I get up and
I need to drink loads of coffee and smoke loads of
fags to wake me up.
Habit and addiction were also raised as barriers to ces-
sation, although interestingly only a small number of the
participants discussed these factors.
[Marion, A/N] I don’t even think about half the
cigarettes that I smoke, they just automatically get lit.
And sometimes halfway through I go, why am I
smoking this? . . . . It’s not like a conscious, you know, a
conscious thing that I’m smoking, it’s just so habitual.[Euan, S] I don’t really like smoking . . . . I’m addicted
to the nicotine.Another factor discussed by many was the enjoyment
associated with smoking. Participants commonly stated
that it was very hard to give up something that was per-
ceived as pleasurable.
[Peter, S] And, eh, just the pure enjoyment having a _ _
a draw of a cigarette. And, eh, the way it makes me feel.[Jenny, A] I love it. It’s _ _ to be honest I’d rather
smoke than eat. I don’t get that much enjoyment out
of eating, but I enjoy a cigarette.
While some stated that they believed they could stop
smoking, it was more common for participants to say
Table 3 Professionals (demographic variables)
n = 54 Frequency Percent
Professional group
Psychiatrist 9 17
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their own ability to do so.
[Margaret, S] I just don’t have the oomph at the minute.Mental health Nurse 23 43
Occupational Therapist 7 13
Psychologist 2 4
Social Worker 5 9






30-39 years 15 28
40-49 years 25 46
50-59 years 10 18
60 + years 1 2
Range 26–62 years; Median 44 years
Smoking status
Never smoker 26 48
Former smoker 19 35
Current smoker 9 17
Note: All percentages have been rounded up/down and so may not add up
to 100%.[Cathy, S] I’m not confident that I could stop. I badly
need some confidence.
Levels of motivation appeared to fluctuate, depending on
how well the participants were, with levels of self-efficacy
seemingly linked to both mental health and previous failed
cessation attempts. Also, as indicated below, a nihilistic
tone was common in many when discussing this issue.
[David, A] I’d like to stop but I know I won’t . . . I
know I’d get healthier, I know that. I think the
majority of it has to come from me and I’ve no got
the willpower to do it.
A reported lack of encouragement by health profes-
sionals, particularly mental health professionals, also
appeared to function as a barrier to cessation. It seemed,
from what was described, to be relatively uncommon for
mental health professionals to raise the issue of smok-
ing/smoking cessation or to encourage their clients/pa-
tients to think about stopping smoking. In a small
number of instances professionals were reported as dis-
couraging thoughts of cessation, apparently concerned
that a cessation attempt might have a negative impact
on their client’s mental health.
[Alison, A] Nobody’s ever raised the issue, not in here
[mental health resource centre]. To be quite honest,
when I was in [psychiatric hospital] most of the patients
smoked, the staff just weren’t concerned at all.[John, S] My [CPN] said it’s no’ for me to tell you to
stop smoking, you should think about the effects of it
[stopping] on your mental illness. I was fine with that.
One participant believed that the professionals she had
contact with during a cessation attempt had been unaware
that her medication levels should have been monitored
during a cessation attempt. From what she described, her
experience was functioning as a key barrier to future ces-
sation attempts.
[Debbie, F, S] I tried stopping before and it was the
clozapine that done it. My speech was slurred and I
was falling all over the place. My doctor thought I’d
had a stroke. Now I’m too scared to stop smoking.
While only one participant raised this issue, it is im-
portant as it highlights the added complexity involved instopping smoking when a person has a mental health
problem and has been prescribed medications such as
clozapine, which is an anti-psychotic. Smoking induces
an enzyme which is involved in metabolising a number
of psychiatric drugs [26]. This means that smokers may
require higher levels of prescribed drugs to achieve the
required therapeutic effect. When someone stops smok-
ing, levels of the enzyme fall, resulting in a reduced rate
of metabolism and a rise in drug levels [26]. Medication
levels may therefore need to be reduced during a cessa-
tion attempt to maintain the required therapeutic effect
whilst preventing toxicity.Potential facilitators
When discussing factors that encouraged them to think
about stopping smoking, the majority of the participants
with MHPs discussed concerns about their physical
health and the cost of smoking. A few also commented
on encouragement and support from professionals.
Smoking-related health problems were common. Re-
spiratory problems were discussed most frequently, with
some reporting that they had heart disease and/or circu-
latory problems. It was evident that the majority were
aware of the impact of smoking on their health and
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by a health problem.
[Jenny, A] Aye, well I’ve got angina. So I really
shouldn’t be smoking at all. And I did get away down
tae, about five a day [from 20]. And I was . . . doing
well and then something [stressful] happened and out
came the cigarettes again. So I’m away back up to
where I was.[Alan, S/A] I am concerned because my breathing’s
really bad, especially when the lift’s down, I’ve got to
walk up stairs and I only walk up two flights of stairs
and I’m knackered . . . I tried to stop but it’s like a
drug, it gets a hold of you and you cannae.
Also, many reported that their disposable income was
low and that a high proportion of this was spent on
tobacco.
[Debbie, S] I’m smoking 60 a day. There’s seven days
in the week, so that about £110. I’d like to stop
actually, but I cannae. It’s a lot out my income.[Marion, A/N] Well, 40 cigarettes a day, £10, nearly
£11 a day. Well, I get £84 a week income support, and
about £70 odd of that goes on cigarettes.
However, while the high cost of manufactured ciga-
rettes appeared to encourage thoughts of cessation in
some, for others it encouraged use of cheaper and po-
tentially more harmful forms of tobacco i.e. ‘roll your
own’ and illicit tobacco.
[Bob, S] [I buy] about two or three 25 g packets and
then I buy tips and paper . . . as well, so it’ll come to
about £18.[Carol, N] As long as it’s a fag, and you’re needing a
fag, a fag’s a fag, you don’t care. Off the back of a
lorry, you’ll take them.
Finally, while lack of encouragement by mental health
professionals appeared to function as a barrier to cessa-
tion attempts, a small number of the participants said
that mental health professionals had raised the issue and
attempted to provide support. Also, it appeared to be
more common for other professionals such as general
practitioners and hospital consultants to raise the issue.
[Fiona, S] It was my [community psychiatric nurse]
that got me information about stopping smoking. I
went to the GP and then went to the chemist to get
the patches and I went every week [to get support].[Alison, A] I attend the respiratory consultant about
every four to six weeks, and it’s basically every time I
go, she’s on at me about stopping smoking.
Views of the professionals
All of the HSCPs had regular contact with people with
MHPs who smoked. Their views on barriers and poten-
tial facilitators to smoking cessation in this client group
are presented below, followed by their thoughts on their
own health promoting role. More barriers than facilita-
tors were discussed.
Barriers
The HSCPs reported that while some of their clients had
attempted to stop or reduce their consumption over the
years, it was rare for clients to manage to stop smoking
successfully. Cutting down or stopping appeared to be
particularly uncommon in people with schizophrenia.
[Ben, psychia.] It does happen but it happens so rarely
that you can almost name the people that have done
it. It’s certainly not common.[Hazel, psychia.] We deal with the severer end of the
spectrum and few manage to stop.
Barriers highlighted during the interviews included social
networks/norms, lack of motivation/self-efficacy, prioritisa-
tion of mental health over physical health and a reluctance
to access mainstream smoking cessation services.
In line with what was discussed by people with MHPs,
the HSCPs stated that the norm was for people with en-
during mental health problems to smoke and to be in
the company of others who smoke.
[Derek, N] They often have limited social contacts
and so we introduce them to other agencies and
they’re nearly all linked to mental health, so the
friends they make are all linked with the psychiatric
services. It narrows their social outlook and the only
other people they come into contact with are people
similar to themselves who smoke.
Where smoking was the norm, attempting to stop
smoking was recognised as being particularly difficult.
[Jack, N] It would be a bit of a shock if somebody in
their [social] group were to announce they were going
to stop smoking.[Jan, N] These clients mix in the same circles. So if one
tries to give up, you know, somebody’s always there to
kind of sabotage it in some way, not that they are maybe
knowingly doing that, but you know, offering them a fag.
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ing mental health problems are in employment. This
meant they were not greatly influenced, on a day to day
basis, by restrictions on smoking associated with the UK
ban on smoking in enclosed public places.
[Ben, psychia.] I think there’s less encouragement in
as much that they’re not regularly having to reduce
their smoking because of work or social activities.
Many people with enduring MHPs were said to live
alone, with some rarely going out and the HSCPs felt
that this also contributed to their continuing to smoke.
[Peter, psychia.] A lot of people with chronic mental
health problems find themselves sitting in all day
doing nothing and to smoke fills up their time.
The influence of mental illness on their clients’ ability
to stop smoking was discussed at length. Problems with
motivation appeared to be common in many, particu-
larly in people with schizophrenia.
[Faith, SW] Knowing myself how hard it is to stop I
think it must be incredibly difficult. I mean when you
can’t maybe apply the logic that we would apply [when
trying to stop] coupled with a lack of motivation I think
it must be incredibly difficult. And the negative
symptoms of psychotic illnesses, that doesn’t help.[Nina, N] I think the motivation and willpower is
probably more difficult . . . Motivation is a big issue
anyway as part of their illness. You know lack of
motivation, the ability to sustain things . . . even with
day to day stuff, motivation is a big issue.
Also, resonating with the views of the participants with
MHPs, levels of self-efficacy were thought to be low in
many clients and this was seen as a key barrier to smok-
ing cessation.
[Peter, psychia.] I think that an internal barrier is that
people think “I will never manage to give up.” So it’s a
confidence issue.
The majority of the HSCPs stated that in recent years
there had been more of a focus on health promotion activ-
ities when working with people with mental health prob-
lems. From what was discussed, smoking and smoking
cessation appeared to be something that was raised; how-
ever, that said, it was evident that mental health was the
priority across all professional groups, and there was
concern that attempting to stop smoking could be too
stressful for many.[Becky, N] I think [we] are less likely to intervene
with someone who has a mental health problem.[Henry, GP] You get tied up with, you know, mental
health issues and you get caught up with that in a
consultation and you don’t get round to other things.
The HSCPs also felt that their clients were more
concerned about maintenance of their mental health.
[Amy, psychia.] I think they’re less motivated and
inclined to seek preventative health strategies, they’re
more worried about keeping well [mentally] on a day
to day basis than looking after their long-term
[physical] health.[Suzanne, OT] I think they’re trying to work on their
mental health and concentrating on that so everything
else seems to go out of the window.
Many of the HSCPs reported that people with MHPs
are often reluctant to engage with/access mainstream
services. This meant that it could be difficult to gain ac-
cess to the type of support that was required to success-
fully stop smoking.
[Erica, OT] Their mental health it acts as a barrier, to
even going to the shops sometimes, you know, basic
skills like getting themselves ready. And so trying to
stop smoking, their mental health problem stops them
engaging with smoking cessation services.[Kev, N] With that very chronic group, you know, it’s
difficult enough for them to engage with us when
we're assertively reaching out to them. They’re not
going to go down to the local anti-smoking clinic. So
their condition is a barrier to engagement.Potential facilitators
Reasons for attempting to stop or to cut down were con-
sidered by the HSCPs to be similar, to the large extent,
to reasons in the wider population, that is, a desire to
improve physical health and to increase disposable in-
come. However the HSCPs believed that unique to this
client group was the influence of their mental health and
many clients were reported as only feeling motivated to
try to stop smoking when their mental health was
well controlled. Finally, a small number of the HSCPs
discussed their own role and that of other HSCPs in en-
couraging cessation attempts.
The HSCPs felt that smoking-related health problems,
either personal or in a family member, encouraged at-
tempts to reduce or stop smoking in some.
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breathing difficulties, chest infections, bronchitis,
things like that that can encourage them to try to stop
or reduce.[Pat, psychia.] It says “smoking kills” on the packs so
they are aware of that, to some extent, but they think
“it won’t be me that gets lung cancer” . . . . Sometimes
having someone who gets seriously ill from cancer
within their own family can be a trigger to them to
start to address their smoking, ‘cos then it’s a bit
closer to home.
As discussed by the participants with MHPs, the
HSCPs commented on the fact that the disposable in-
come of many of their clients was low and that a large
proportion of their income was used to purchase ciga-
rettes/tobacco. Some felt that many of their clients
would always prioritise spending money on tobacco.
[Laurie, N] They maybe need a loaf of bread and
twenty fags and twenty fags always comes first.
However, an increase in disposable income associated
with stopping smoking was considered to be a potential
trigger for some.
[Frances, OT] I have spoken to a lot of patients and I
think that finance seems to be a big thing. I think
when they look at their funds and think, all of this is
going on fags.[Laurie, N] I think that financial issues can be a
motivator for [a few]. From past experience we had
someone who saved about £900 . . . once she
[stopped] she could see all the money adding up,
which she found really good. So getting them
stopped for a short period to begin with can let them
see that.
A few reported that if a client had had a sustained
period where their mental health was stable they may
start to consider improvements that could be made to
their physical health.
[Rebecca, OT] I think if they are generally feeling
better within themselves, when their mental health is
more stable, they might have an increase in their
mood and then be a bit more motivated to try to look
at things in their lives [like smoking].
Finally, some discussed the importance of their own
role, and that of other professionals, in encouraging/po-
tentially triggering cessation/reduction attempts.[Anne, N] It’s part of the role. We talk about smoking
and its effects on them, how many they are smoking
and if there is an interest in cutting back or stopping
we look at ways we can help them to do that. Some
clients will say straight no and you will bring it up
now and again. We look at health and wellbeing on a
regular basis now with this client group.
Health promoting role of professionals
Following the general discussion of barriers and facilita-
tors, the HSCPs were asked to discuss their views of
their own role in raising the issue of smoking/smoking
cessation in more detail. A small number did not believe
they had a role.
[Ed, SW] That’s their sort of lifestyle if they wish to
smoke, I’m not there to say “Oh you could get lung
cancer in however many years” and stuff like that. I
don’t see it as my role.[Caryn, psychia.] It isn’t something that I incorporate
into my routine assessment.
However, this was relatively rare and most discussed
the increased interest in promoting the physical health
of this client group in recent years, stating that raising
the issue of smoking was definitely part of their role.
[Jason, N] We have a responsibility to promote wellness
and promote wellbeing, both physically and mentally.[Wendy, OT] We run a healthy lifestyle group in the
health centre once a week and we cover all aspects of
health including smoking.[Gay, GP] There was a change a number of years ago,
with the introduction of our new GP contract, we are
obliged now to invite people with severe and enduring
mental illness for an annual review, part of which
includes addressing things like diet and smoking . . ..
So that helps us, having a special appointment to
discuss the person in total, not just focusing on their
mental health.
In some cases the approach appeared to be very
proactive.
[Aaron, GP] We refer to the smoking cessation clinic
. . . . I really sell the smoking cessation service, they’re
very good and very accommodating.[Mo, N] We actually offer a service in here [Resource
Centre] and because they are familiar with us, they
are more keen to take it up.
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role, when asked to describe what they did, their input
appeared to be quite minimal; they felt it should be part
of their role but other than asking if a client smoked
(often information gathered during an initial assessment)
they did not raise the issue on a regular basis nor say
very much when it was mentioned.
[Jack, N] It’s not a major role for us . . . If someone
was smoking 60 or 70 fags a day I might ask them to
at least have a think about what they are doing to
themselves, but that’s as much as we can do.
The majority of the professionals discussed the import-
ance of the relationship they had with their clients and it
was fairly common, in this context, for them to report that
it was not their role to tell clients “what to do”. Some
appeared to feel that the issue should be raised but not
pushed too hard and others were concerned that, if they
were to discuss smoking, their clients might feel they were
being judged.
[Patricia, SW] Regardless of their physical health they
prioritise their cigarettes as they need this wee crutch,
don’t they. It’s about choices and control, it’s
respecting the individual.[Tim, GP] You don’t want to sound like this didactic
middle class professional telling this kinda poor
unemployed mentally unwell person, “Would you like
to get your life together and stop smoking?”. . . . It’s
often less important to them.[Pat, psychia.] I have a duty to remind them of the
dangers and various things but I don’t make too
much of a fuss about it for fear of impairing my
relationship.
Concern for their clients was obvious, but fear of dam-
aging relationships appeared to get in the way of effect-
ive delivery of smoking cessation interventions.
The influence of the professionals’ own smoking status
on their health promoting role was also raised by some
as something that influenced their health promoting
role. The most common feeling appeared to be that rais-
ing the issue of smoking was hypocritical if you were a
smoker yourself.
[Amy, psychia.] It is a difficult one because on a
personal level I smoke, so I have my own demons.[Ed, SW] It would be a bit hypocritical of me to give
one of my clients a lecture about smoking when I
probably smoke just as much, or potentially more.However, a few felt that their own smoking status assisted
their understanding of how difficult it is to stop smoking.
[Mark, GP] Having tried on several occasions myself
and not succeeded, I know all of the pitfalls. I can talk
to them as somebody, who I mean, it’s not as if I’m a
person who hides the fact that I smoke. They all know
I smoke . . . . So I can talk to them as someone who
has the same addiction.
Some of the professionals, who were former smokers,
felt their own experience of stopping could be useful in
encouraging clients to stop; however, as discussed below,
being a former smoker could also function as an impedi-
ment to the issue being raised.
[Deirdre, N] I have to be very careful because a lot of
them are long term maintenance patients and they
know that I smoked for years so I have to be very
careful and not come across as preaching because I
have stopped.
Finally, when discussing their own health promoting
role, the majority of the HSCPs stated that they had not
undertaken any smoking cessation training. This appeared
to impact on the knowledge and skills they were able to
bring to conversations they had with clients about smok-
ing/smoking cessation.
[Helen, N] My knowledge isn’t great. If I knew a bit
more I could pass it on to clients.
Some of the mental health professionals had undertaken
training in general addictions but those who had tended
to have a greater interest in addressing alcohol consump-
tion and the use of illicit drugs. Smoking was not consid-
ered to be a priority when clients had other addictions.
[Frances, OT] The patients that I tend to see it’s the
choice between should I address the heroin use or the
smoking. It’s that kind of extreme.
Knowledge of generic smoking cessation guidelines
was limited.
Discussion
Our aim was to determine the principal barriers and facili-
tators to smoking/smoking cessation in people with
MHPs, with a view to informing the design and content of
tailored smoking cessation interventions for this client
group. In order to do this, interviews were conducted with
27 people with MHPs and 54 HSCPs who have regular
contact with this client group. The findings are discussed
below, viewed through the lens of social cognitive theory.
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Personal factors, including low levels of motivation and
self-efficacy appeared to function as key barriers to
smoking cessation for many. These issues were discussed
by the participants with MHPs and the HSCPs, and
seemed to be particularly problematic for people with
schizophrenia and schizo-affective disorder.
A central tenet of social cognitive theory is self-
efficacy. Bandura [18] posits that a person must believe
in their own ability to change a particular behaviour (in
this case stop smoking) and must perceive an incentive
to do so, that is, the person’s positive expectations of
changing the behaviour must outweigh any negative ex-
pectations. Additionally, a person must value the out-
comes or consequences that s/he believes will occur as a
result of changing the behaviour. As the expected out-
comes are filtered through a person’s expectations or
perceptions of being able to perform the behaviour in
the first place, self-efficacy is believed to be the single
most important characteristic that determines a person’s
ability to change their behaviour [18].
While the participants in this study generally believed
their physical health would improve if they stopped
smoking and their disposable income would increase,
more important to many was an expectation that, if they
stopped or attempted to stop smoking, their mental
health would deteriorate, anxiety levels would increase,
they would lose an important emotional coping resource
and they would have given up something they enjoyed/
found pleasurable. The barriers therefore outweighed
the potential facilitators and, as a result, impacted nega-
tively on levels of motivation and self-efficacy. Low levels
of motivation and self-efficacy in this client group, when
considering smoking cessation, have been raised previ-
ously [27].
Another important concept discussed by Bandura [18]
is ‘behavioural capacity,’ which refers to the knowledge
and skills required to perform a particular behaviour.
Based on accounts from the professionals in particular,
it is likely that stopping smoking will present particular
challenges for a proportion of people with severe and
enduring mental health problems who struggle with cog-
nitions and basic day to day tasks. For example, up to
75% of people with schizophrenia are thought to have
significant cognitive impairment [28].
Environmental factors
The importance of the social and physical environment
in encouraging or discouraging a particular behaviour is
also discussed by Bandura [18]. In the current study, the
role of social influence was particularly evident in the
maintenance of smoking in people with MHPs. There
was a strong norm for smoking in friends and family
and in the mental health environment in which theyfound themselves. Also, there appeared to be few positive
role models, particularly other people with MHPs, who
had managed to stop smoking successfully, and this lim-
ited opportunities for observational learning [18]. Obser-
vational learning occurs by watching the actions and
outcomes of others’ behaviour and therefore observing
successful cessation attempts in other people with MHPs
is particularly important in encouraging behaviour change
[19]. The norm of smoking in the mental health field is
well documented e.g. [5,29,30] and this prevails, despite
the introduction of smoke-free policies in secondary care
settings. This is clearly a factor that makes it more difficult
for people with MHPs to stop smoking.
The potential for mental health professionals to encour-
age and support cessation attempts was evident, as was
their potential to discourage thoughts of cessation. It is
therefore essential that this professional group is aware of
the influence of their own beliefs and attitudes on their cli-
ents’ smoking-related behaviour. Genuine concern for their
clients was obvious, but fear of damaging relationships, in-
creasing stress and a belief that attempting to/stopping
smoking may damage mental health often appeared to get
in the way of the effective delivery of smoking cessation in-
terventions. Fear of damaging relationships in not unique
to the mental health field [31]; however, it is clearly some-
thing that needs to be addressed. Mental health profes-
sionals should also consider the impact of their own
smoking status on their attitudes towards their health pro-
moting role. The prevalence of smoking in mental health
professionals is known to be high compared to other pro-
fessional groups. A recent survey found that 25% of mental
health professionals were current smokers, with rates being
particularly high in nurses (32.2%) [32].
The concept of behavioural capacity, discussed previ-
ously in relation to people with MHPs, is also relevant for
professionals, as they must have the appropriate know-
ledge and skills to raise the issue of smoking/smoking ces-
sation appropriately and to give evidence-based advice. In
the current study, knowledge levels were often low and
few had received smoking cessation training to equip them
with the knowledge and skills required. It is interesting to
note that a number of the HSCPs felt that discussing
smoking was about “telling people what to do” or “giving
people a lecture.” Comments such as these are important
as they demonstrate a lack of understanding of the role of
professionals in delivering brief smoking cessation inter-
ventions and highlight the need for training. Lack of
smoking cessation training has been highlighted in other
studies, for example a recent survey of 375 mental health
professionals found that only 7% had undertaken training
[32]. Compulsory training, linked to a set of core compe-
tencies may be a solution. Also, the inclusion of formal
smoking cessation education/training in undergraduate
and post-graduate programmes would seem appropriate.
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base to guide practice when working with people with en-
during mental health problems is currently limited.
Finally, when considering access to intensive smoking
cessation support, while a network of smoking cessation
services exists in the UK and some people with MHPs
will attend, a significant proportion of people with en-
during mental health problems, particularly those with
schizophrenia or schizo-affective disorders were reported
as reluctant to engage with ‘mainstream’ services. Rea-
sons included experiencing discomfort in meeting new
people, being in unfamiliar settings and feeling ‘different’
to others attending the service. The settings in which
smoking cessation services are delivered are therefore
particularly important for this client group. The diffi-
culty that people with MHPs can have in accessing
mainstream services is well-documented e.g. [33].
Attributes of smoking
While the participants voiced negative aspects to smok-
ing, including the impact on their health and the finan-
cial cost, the perceived therapeutic qualities (e.g. stress
reduction, maintenance of mental health and reduction
in medication side-effects) appeared to be more import-
ant for most. However, while stress-relief and enjoyment
are commonly reported reasons for continuing to smoke
(in all smokers), evidence suggests that habit and nico-
tine dependence are, in fact, more influential than most
people realise [34,35]. Nicotine acts on the mid-brain,
creating impulses to smoke caused by stimuli associated
with smoking. Also when nicotine levels drop smokers ex-
perience symptoms such as anxiety, irritability and low
mood which are then relieved by smoking a cigarette [34].
Smoking is therefore thought to cause, rather than allevi-
ate, stress, anxiety, and low mood [35]. This is particularly
important to note in people with MHPs, who are known
to have high levels of addiction [5].
Strengths and limitations
With a desire to add the limited evidence base in this area,
this study sought to undertake a theoretically-driven ex-
ploration of key barriers and facilitators to smoking cessa-
tion in people with enduring MHPs who live at home in
the community. Data were collected from a diverse group
of professionals and individuals with MHPs across a large
geographical area and this enhances the potential transfer-
ability of the findings.
Despite attempts to do so, we were unable to recruit
participants with MHPs from black and minority ethnic
groups and this is a limitation. Also, similar to other
qualitative studies, there is no way of knowing whether
the views of people with MHPs who participated in the
study are similar or different to non-participants. When
considering the professionals, smokers may have beenless likely to participate than non-smokers. As discussed,
a recent survey of the prevalence of smoking in mental
health professionals demonstrated that 25% are current
smokers [32]. In the current study, only 17% of the par-
ticipants were smokers. This may have had some influ-
ence on the findings.
Conclusions
Many opportunities to encourage and support smoking
cessation in people with MHPs are currently missed.
The reasons are complex but the limited evidence base
to guide practice/interventions is certainly an impedi-
ment. The increased understanding provided by our
study findings and literature review suggest that behav-
ioural interventions for this client group should address
following: levels of self-efficacy; motivation; ways of cop-
ing with stress and anxiety that bypass the urge to
smoke; concerns about deterioration in mental health;
knowledge and skills associated with making a cessation
attempt (including knowledge of addiction); and, an un-
derstanding of the link between doses of certain psycho-
tropic medications and smoking/smoking cessation.
Behavioural interventions should also consider the in-
volvement of role models i.e. other people with enduring
MHPs who have stopped smoking successfully. The role
of the multi-disciplinary team who have regular contact
with this client group is central and all staff should receive
smoking cessation training that addresses knowledge, atti-
tudes and skills. Services/interventions designed to pro-
vide intensive cessation support should take account of
the fact that people with enduring mental health problems
are often reluctant to access mainstream services; for
some, smoking cessation support should be delivered in
settings they are familiar with (e.g. mental health resource
centres). If people with mental health problems are able to
attend mainstream cessation services there is a need for
cessation advisors to work in close partnership with the
mental health professionals who have regular contact with
these clients.
When considering pharmacotherapy, our review of the
literature suggests a need for further trials of nicotine re-
placement therapy and varenicline with this client group
[9,10]. Also, levels of psychiatric medications (e.g. clozapine)
should be closely monitored during cessation attempts.
In conclusion, there is a clear need for the behavioural
components of smoking cessation interventions to be the-
oretically driven. Our intention in undertaking this re-
search was to make a contribution to the growing evidence
base in this area, providing information that can be used to
design and evaluate smoking cessation interventions for
people with enduring mental health problems.Competing interests
The authors declared that they have no competing interest.
Kerr et al. BMC Public Health 2013, 13:221 Page 12 of 12
http://www.biomedcentral.com/1471-2458/13/221Authors’ contributions
SK led on the design and conduct of the study, the analysis and interpretation
of the data and the writing of the paper. She oversaw the recruitment process
and the generation of the data. CW led on the recruitment and generation of
the interview data and contributed to the writing of the paper, including the
interpretation of the findings. CK contributed to the design and conduct of the
study, the interpretation of the data and the writing of the paper. She also
advised on the study’s theoretical underpinnings. RH contributed to the design
and conduct of the study and the writing of the paper. HW contributed to the
design and conduct of the study, the interpretation of the data and the writing
of the paper. All authors approved the final version of the manuscript.
Authors’ information
SK, BA, MSc (Med. Sci.), PhD, RN SCPHN, Reader in Public Health, Institute for
Applied Health Research, Glasgow Caledonian University. CW, Dip. Alc. &
Drug Studies, RGN, RMN, Research Assistant/Mental Health Nurse, School of
Health & Life Sciences, Glasgow Caledonian University. CK, BA (Hons), MSc,
PhD, Reader in Psychology/Health Psychologist, Institute for Applied Health
Research, School of Health & Life Sciences, Glasgow Caledonian University.
RH, Consultant Psychiatrist, BSc (Hons), FRCPsych, MD, NHS Greater Glasgow
& Clyde/Psychiatric Research Institute of Neuroscience, University of Glasgow.
HW, MN, PhD, RMN, RNT, Professor of Nursing/Mental Health Nurse, School
of Health and Life Sciences, Glasgow Caledonian University.
Acknowledgements
We acknowledge the important contributions made by Professor Robin
McCreadie, Dr Murray Lough and Dr Barry Gibson-Smith in the initial
development of this programme of research. We also thank the Scottish Primary
Care Research Network and key workers for their assistance with recruitment. In
particular, we express our gratitude to the people with mental health problems
and the professionals who agreed to share their views and experiences. The study
was funded by the National Prevention Research Initiative, a consortium of
funding bodies including the MRC, ESRC, DoH, Chief Scientist Office of the
Scottish Government Health Department, Cancer Research UK, British Heart
Foundation, Diabetes UK, Research and Development office for the Northern
Ireland Health & Social Services and the Welsh Assembly Government.
Author details
1Institute for Applied Health Research, School of Health & Life Sciences,
Glasgow Caledonian University, Cowcaddens Road, Glasgow, Scotland G4
OBA, UK. 2School of Health & Life Sciences, Glasgow Caledonian University,
Scotland, UK. 3NHS Greater Glasgow & Clyde/Psychiatric Research Institute of
Neuroscience, University of Glasgow, Scotland, UK.
Received: 11 October 2012 Accepted: 5 March 2013
Published: 12 March 2013
References
1. Department of Health (DoH): Choosing Health: supporting the physical health
needs of people with severe mental illness. London: DoH; 2006.
2. Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA: Excess cancer
mortality in psychiatric patients. Can J Psychiatry 2008, 53:753–761.
3. McCreadie R, Scottish Schizophrenia Lifestyle Group: Diet, smoking and
cardiovascular risk in people with schizophrenia: descriptive study.
Br J Psychiatry 2003, 183:534–539.
4. Coulthard M, Farrell M, Singleton N, Meltzer H: Tobacco, alcohol and drug
use and mental health. London: Stationery Office; 2002.
5. Campion J, Checinski K, Nurse J, McNeill A: Smoking by people with
mental illness and benefits of smoke-free mental health services.
Adv Psychiatr Treat 2008, 14:217–228.
6. Department of Health (DoH): Health inequalities: Progress and next steps.
London: DoH; 2008.
7. National Institute for Health and Clinical Excellence (NICE): Brief interventions
and referral for smoking cessation in primary care and other settings. Quick
reference guide. London: NICE; 2006. http://www.nice.org.uk/nicemedia/live/
11375/31866/31866.pdf (accessed September 2012).
8. National Institute for Health and Clinical Excellence: Smoking cessation
services (PH10). London: NICE; 2008. http://www.nice.org.uk/PH010
(accessed September 2012).
9. Banham L, Gilbody S: Smoking cessation in severe mental illness: what
works? Addiction 2010, 105:1176–1189.10. Tsoi DT, Porwal M, Webster AC: Efficacy and safety of bupropion for
smoking cessation and reduction in schizophrenia: a systematic review
and meta-analysis. Br J Psychiatry 2010, 196:346–353.
11. Information and Statistics Division of NHS Scotland (ISD): Prescribing of
smoking cessation interventions. Edinburgh: ISD; 2010. http://www.
isdscotland.org/isd/4636.html (accessed Jul 2012).
12. Purvis TL, Nelson LA, Mambourg SE: Varenicline use in patients with mental
illness: an update of the evidence. Expert Opin Drug Saf 2010, 9:471–482.
13. Faculty of Public Health: Mental health and smoking. London: Faculty of
Public Health; 2008. http://www.fph.org.uk/uploads/
ps_mental_health_and_smoking.pdf (accessed September 2008).
14. National Institute for Clinical Excellence (NICE): Smoking cessation – mental
health services: call for evidence. London: NICE; 2012. http://guidance.nice.
org.uk/PHG/51/MHCallForEvidence (accessed August 2012).
15. Medical Research Council (MRC): Developing and evaluating complex
interventions: new guidance. London: MRC; 2008. http://www.mrc.ac.uk/
complexinterventionsguidance (accessed May 2008).
16. McEvoy P, Richards D: Critical realism: a way forward for evaluation
research in nursing. J Adv Nurs 2003, 43:411–420.
17. Benton T, Craib I: Philosophy of social science. Hampshire: Palgrave; 2001.
18. Bandura A: Social foundations of thought and action: A cognitive social
theory. NJ, Prentice-Hall: Englewood Cliffs; 1986.
19. Bandura A: Health promotion by social cognitive means. Health Educ
Behav 2004, 31:143–164.
20. Byrne M: Sampling for qualitative research. AORN 2001, 73:497–498.
21. World Health Organisation (WHO): International classification of diseases and
related health problems (10th revision). Geneva: WHO; 2008. http://apps.who.
int/classifications/apps/icd/icd10online/ (accessed April 2008).
22. Pope C, Ziebland S, Mays N: Qualitative research in health care: analysing
qualitative data. Br Med J 2006, 320:114–116.
23. Ritchie J, Spencer L: Qualitative data analysis for applied policy research.
In Analysing qualitative data. Edited by Bryman A, Burgess R. London:
Routledge; 1994.
24. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström K: The fagerström test
for nicotine dependence: a revision of the fagerström tolerance
questionnaire. Br J Addict 1991, 86:1119–1127.
25. Scottish Government: Scottish Index of Multiple Deprivation. Edinburgh:
Scottish Government; 2010. http://www.scotland.gov.uk/Topics/Statistics/
SIMD (accessed September 2011).
26. Schroeder SA, Morris CD: Confronting a neglected epidemic: tobacco
cessation for persons with mental illness and substance abuse problems.
Annu Rev Public Health 2010, 31:297–314.
27. Mann-Wrobel MC, Bennett ME, Weiner EE, Buchanan RW, Ball MP: Smoking
history and motivation to quit in smokers with schizophrenia in a
smoking cessation program. Schizophr Res 2011, 126:277–283.
28. O’Carroll R: Cognitive impairment in schizophrenia. Adv Psychiatr Treat
2000, 6:161–168.
29. Ratschen E, Britton J, McNeill A: Implementation of smoke-free policies in
mental health in-patient settings in England. Br J Psychiatry 2009, 194:547–551.
30. McNeill A: Smoking and patients with mental health problems. London:
Health Development Agency; 2004.
31. Coleman T, Murphy E, Cheater F: Factors influencing discussion of
smoking between general practitioners and patients who smoke: a
qualitative study. Br J Gen Pract 2000, 50:207–210.
32. Kerr S, Wilson B, Soundararajan K, Meldrum D, Lockie S: Smoke-free mental
health settings: exploring the knowledge, attitudes and experience of staff.
Glasgow: Glasgow Caledonian University/NHS Greater Glasgow & Clyde; 2011.
33. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ: Cardiovascular
disease and diabetes in people with severe mental illness: position statement
from the European psychiatric association. Eur Psychiatry 2009, 24:412–424.
34. Hughes JR: Effects of abstinence from tobacco: etiology, animal models,
epidemiology and significance. Nicotine Tob Res 2007, 9:315–327.
35. Aveyard P, West R: Managing smoking cessation. Br Med J 2007, 335:37–41.
doi:10.1186/1471-2458-13-221
Cite this article as: Kerr et al.: Breaking the habit: a qualitative
exploration of barriers and facilitators to smoking cessation in people
with enduring mental health problems. BMC Public Health 2013 13:221.
